Clinical trial
Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI
NCT01307527 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI
- Lead sponsor
- Hadassah Medical Organization
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 1 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brittle cornea syndrome, ehlers-danlos syndrome type 6